Health Care · Life Sciences Tools

Medpace Holdings, Inc. MEDP

$589.37-12.01 (-2.00%)delayed quote · as of 2026-07-28 07:03 UTC

Open MEDP in the workspaceCharts, statements, and the evidence behind every figure — free to start.

Market cap

$16.5B

Previous close

$601.38

Volume

415K

52-week range

$373.00 – $677.90

Verdictconfidence 88% · high

Growth and Quality stand out; value flashes caution.

4 of 5 dimensions score well; value flashes caution.

Value402/5 checks

Growth1005/5 checks

Quality753/4 checks

Health672/3 checks

Momentum603/5 checks

Fair-value estimate $718.11 per share (2-stage FCF · individual beta · 10Y Rf 4.7%) — the price sits 18% below it.

Every check behind these scores — with its numbers, source, and evidence link — is in the workspace. Free account required.

Key ratioslatest filing FY 2025

Value

P/E TTM

37.1

P/E FWD

31.4

EV/EBITDA TTM

25.1

PEG

4.30

FCF yield TTM

4.3%

Growth

Revenue 3y

+20.1%/yr

Revenue YoY

+20.0%

Expected EPS

+18.0%

Quality

Piotroski F

5 / 9

ROIC

ALAN GLOBAL INTELLIGENCE · alanglobalintelligence.comquote as of 2026-07-28 07:03 UTC · fundamentals FY 2025 · SEC EDGAR

Verdict

Reading MEDP’s filed statements…

Continue with MEDP in ALAN

Full evidence trail, financial statements back a decade, valuation history, charts, and alerts.

Open in the workspace Create free account

For information and research only. Not investment advice. ALAN does not place trades or execute orders. Figures come from the sources shown and can lag the market; verify independently before making decisions. Past performance is not predictive of future results.